Rakuten Investment Management Inc. Buys New Stake in Corteva, Inc. $CTVA

Rakuten Investment Management Inc. purchased a new position in Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 109,539 shares of the company’s stock, valued at approximately $9,132,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of Corteva in the 2nd quarter valued at approximately $4,560,180,000. Harris Associates L P grew its position in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after acquiring an additional 10,675,052 shares during the period. Norges Bank bought a new stake in Corteva in the fourth quarter valued at $504,001,000. Jupiter Topco LLC acquired a new position in Corteva during the second quarter worth $544,246,000. Finally, Bank of America Corp DE acquired a new position in Corteva during the second quarter worth $484,927,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Stock Up 1.9%

Shares of CTVA opened at $84.00 on Friday. The business’s fifty day moving average price is $82.69 and its two-hundred day moving average price is $80.54. The firm has a market capitalization of $56.04 billion, a price-to-earnings ratio of 55.63, a PEG ratio of 2.58 and a beta of 0.57. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. BNP Paribas Exane upped their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. JPMorgan Chase & Co. boosted their price target on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Morgan Stanley raised their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 target price on shares of Corteva in a research note on Monday, August 3rd. Finally, Citigroup boosted their target price on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.